(Q40644022)

22 September 2017

1 reference

title

Alternative mechanisms of action of anti-oestrogens (English)

1 reference

22 September 2017

A A Colletta

1

1 reference

22 September 2017

J R Benson

series ordinal

2

1 reference

22 September 2017

M Baum

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

Breast Cancer Research and Treatment

22 September 2017

1 reference

22 September 2017

31

1 reference

22 September 2017

5-9

1 reference

22 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00689672

22 September 2017

0 references

cites work

Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00689672

In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen

21 January 2018

1 reference

12 December 2020

Desmoid tumours treated with triphenylethylenes

1 reference

12 December 2020

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation

1 reference

12 December 2020

Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells

1 reference

12 December 2020

The steroid and thyroid hormone receptor superfamily

1 reference

12 December 2020

Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptor

1 reference

12 December 2020

Triphenylethylenes: a new class of protein kinase C inhibitors

1 reference

12 December 2020

Insulin-like growth factor II mRNA expression in human breast cancer

1 reference

12 December 2020

Insulin-like growth factors stimulate chemotaxis in human melanoma cells

1 reference

12 December 2020

Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin

1 reference

12 December 2020

Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer

1 reference

12 December 2020

Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; correlations with cytotoxicity

1 reference

12 December 2020

Inositol trisphosphate, a novel second messenger in cellular signal transduction

1 reference

12 December 2020

Effect of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovary.

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Nuclear receptors enhance our understanding of transcription regulation

1 reference

12 December 2020

Insulin-like growth factor receptor expression and function in human breast cancer

1 reference

12 December 2020

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

12 December 2020

High-affinity anti-oestrogen binding site distinct from the oestrogen receptor

1 reference

12 December 2020

Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol

1 reference

12 December 2020

The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta

1 reference

12 December 2020

Induction and autocrine receptor binding of transforming growth factor-beta 2 during terminal differentiation of primary mouse keratinocytes

1 reference

12 December 2020

Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer

1 reference

12 December 2020

Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions

1 reference

12 December 2020

Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture

1 reference

12 December 2020

Regulation of gene expression by nuclear hormone receptors

1 reference

12 December 2020

Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

1 reference

12 December 2020

Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression

1 reference

12 December 2020

Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors

1 reference

12 December 2020

Tamoxifen reduces serum insulin-like growth factor I (IGF-I)

1 reference

12 December 2020

Inhibition of Metastatic Behavior of Murine Osteosarcoma by Hypophysectomy

1 reference

12 December 2020

FIBROBLASTS FROM RELATIVES OF PATIENTS WITH HEREDITARY BREAST CANCER SHOW FETAL-LIKE BEHAVIOUR IN VITRO

1 reference

12 December 2020

Inhibition of protein kinase C by tamoxifen.

1 reference

12 December 2020

Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells

1 reference

12 December 2020

Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment

1 reference

12 December 2020

Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.

1 reference

12 December 2020

Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.

1 reference

12 December 2020

Occurrence of a fetal fibroblast phenotype in familial breast cancer

1 reference

12 December 2020

Primary medical therapy for operable breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00689672

1 reference

Dimensions Publication ID

22 September 2017

0 references

1 reference